291 related articles for article (PubMed ID: 9718055)
1. Cancer risk in women exposed to diethylstilbestrol in utero.
Hatch EE; Palmer JR; Titus-Ernstoff L; Noller KL; Kaufman RH; Mittendorf R; Robboy SJ; Hyer M; Cowan CM; Adam E; Colton T; Hartge P; Hoover RN
JAMA; 1998 Aug; 280(7):630-4. PubMed ID: 9718055
[TBL] [Abstract][Full Text] [Related]
2. Risk of clear-cell adenocarcinoma of the vagina and cervix among US women with potential exposure to diethylstilbestrol in utero.
White MC; Weir HK; Soman AV; Peipins LA; Thompson TD
Cancer Causes Control; 2022 Aug; 33(8):1121-1124. PubMed ID: 35767133
[TBL] [Abstract][Full Text] [Related]
3. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
Huo D; Anderson D; Palmer JR; Herbst AL
Gynecol Oncol; 2017 Sep; 146(3):566-571. PubMed ID: 28689666
[TBL] [Abstract][Full Text] [Related]
4. Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States).
Palmer JR; Hatch EE; Rosenberg CL; Hartge P; Kaufman RH; Titus-Ernstoff L; Noller KL; Herbst AL; Rao RS; Troisi R; Colton T; Hoover RN
Cancer Causes Control; 2002 Oct; 13(8):753-8. PubMed ID: 12420954
[TBL] [Abstract][Full Text] [Related]
5. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
[TBL] [Abstract][Full Text] [Related]
6. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States).
Hatch EE; Herbst AL; Hoover RN; Noller KL; Adam E; Kaufman RH; Palmer JR; Titus-Ernstoff L; Hyer M; Hartge P; Robboy SJ
Cancer Causes Control; 2001 Nov; 12(9):837-45. PubMed ID: 11714112
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in women prenatally exposed to diethylstilbestrol.
Troisi R; Hatch EE; Titus-Ernstoff L; Hyer M; Palmer JR; Robboy SJ; Strohsnitter WC; Kaufman R; Herbst AL; Hoover RN
Int J Cancer; 2007 Jul; 121(2):356-60. PubMed ID: 17390375
[TBL] [Abstract][Full Text] [Related]
9. Findings in female offspring of women exposed in utero to diethylstilbestrol.
Kaufman RH; Adam E
Obstet Gynecol; 2002 Feb; 99(2):197-200. PubMed ID: 11814496
[TBL] [Abstract][Full Text] [Related]
10. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
[TBL] [Abstract][Full Text] [Related]
11. Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening.
Tournaire M; Gondry J; Mauny L; Devouche E; Morice P
J Gynecol Obstet Hum Reprod; 2023 Oct; 52(8):102630. PubMed ID: 37451413
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk in DES daughters.
Verloop J; van Leeuwen FE; Helmerhorst TJ; van Boven HH; Rookus MA
Cancer Causes Control; 2010 Jul; 21(7):999-1007. PubMed ID: 20204493
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
[TBL] [Abstract][Full Text] [Related]
14. Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation.
Titus-Ernstoff L; Troisi R; Hatch EE; Hyer M; Wise LA; Palmer JR; Kaufman R; Adam E; Noller K; Herbst AL; Strohsnitter W; Cole BF; Hartge P; Hoover RN
Epidemiology; 2008 Mar; 19(2):251-7. PubMed ID: 18223485
[TBL] [Abstract][Full Text] [Related]
15. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
Edelman DA
Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
[TBL] [Abstract][Full Text] [Related]
16. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.
Laronda MM; Unno K; Butler LM; Kurita T
Differentiation; 2012 Oct; 84(3):252-60. PubMed ID: 22682699
[TBL] [Abstract][Full Text] [Related]
17. Prenatal diethylstilbestrol exposure and risk of breast cancer.
Palmer JR; Wise LA; Hatch EE; Troisi R; Titus-Ernstoff L; Strohsnitter W; Kaufman R; Herbst AL; Noller KL; Hyer M; Hoover RN
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1509-14. PubMed ID: 16896041
[TBL] [Abstract][Full Text] [Related]
18. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
[TBL] [Abstract][Full Text] [Related]
19. DES exposure and the aging woman: mothers and daughters.
Laitman CJ
Curr Womens Health Rep; 2002 Oct; 2(5):390-3. PubMed ID: 12215312
[TBL] [Abstract][Full Text] [Related]
20. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
